title: Knowledge and attitudes about male circumcision for HIV-1 prevention among heterosexual HIV-1 serodiscordant partnerships in Kampala, Uganda.
abstract: Male circumcision for HIV-1 prevention will require high uptake among at-risk populations. 318 HIV-1 serodiscordant couples in Kampala, Uganda [155 (48.7%) with HIV-1 uninfected male partners] were interviewed about male circumcision for HIV-1 prevention. 77.1% of men and 89.6% of women were aware that circumcision reduces men's risk for HIV-1 acquisition. Almost all understood the partial protective efficacy of circumcision for HIV-1 acquisition and lack of reduced HIV-1 transmission from circumcising HIV-1 infected men. Among couples with uncircumcised HIV-1 negative men (n = 92), 53.3% of men and 88.1% of female partners expressed interest in male circumcision. Previous discussion within the couple about circumcision for HIV-1 prevention was significantly associated with interest in the procedure. HIV-1 serodiscordant couples in Uganda demonstrated a high level of understanding of the partial protective effect of male circumcision for HIV-1 prevention, but only half of HIV-1 uninfected uncircumcised men expressed interest in the procedure.
authors.affiliation: Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda. kmugwanya@gmail.com
authors.forename: Kenneth K
authors.initials: KK
authors.lastname: Mugwanya
authors.forename: Jared M
authors.initials: JM
authors.lastname: Baeten
authors.forename: Edith
authors.initials: E
authors.lastname: Nakku-Joloba
authors.forename: Elly
authors.initials: E
authors.lastname: Katabira
authors.forename: Connie
authors.initials: C
authors.lastname: Celum
authors.forename: Daniel
authors.initials: D
authors.lastname: Tisch
authors.forename: Christopher
authors.initials: C
authors.lastname: Whalen
mesh_terms: D000328:Adult; D017677:Age Distribution; D002944:Circumcision, Male; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D018023:HIV Seronegativity; D006679:HIV Seropositivity / Q000523:psychology / Q000635:transmission; D015497:HIV-1 / Q000276:immunology; D007722:Health Knowledge, Attitudes, Practice; D020010:Heterosexuality; D006801:Humans; D008297:Male; D018454:Spouses / Q000706:statistics & numerical data; D014454:Uganda
references.citation: PLoS Med. 2009 Sep;6(9):e1000109
references.pmid: 19901974
references.citation: Lancet. 2008 Jun 28;371(9631):2183-91
references.pmid: 18586173
references.citation: Lancet. 2009 Jul 18;374(9685):229-37
references.pmid: 19616720
references.citation: Lancet. 2007 Feb 24;369(9562):708-13
references.pmid: 17321321
references.citation: AIDS Behav. 2007 May;11(3):357-63
references.pmid: 17345145
references.citation: PLoS One. 2008 Jan 09;3(1):e1411
references.pmid: 18183292
references.citation: N Engl J Med. 2010 Feb 4;362(5):427-39
references.pmid: 20089951
references.citation: Lancet. 2007 Feb 24;369(9562):643-56
references.pmid: 17321310
references.citation: Health Educ Q. 1984 Spring;11(1):1-47
references.pmid: 6392204
references.citation: BMC Med Res Methodol. 2008 Feb 28;8:9
references.pmid: 18307814
references.citation: AIDS Behav. 2007 May;11(3):341-55
references.pmid: 17053855
references.citation: Lancet. 2007 Feb 24;369(9562):657-66
references.pmid: 17321311
references.citation: J Acquir Immune Defic Syndr. 2002 May 1;30(1):73-80
references.pmid: 12048366
references.citation: AIDS. 2008 Mar 12;22(5):567-74
references.pmid: 18316997
references.citation: PLoS Med. 2005 Nov;2(11):e298
references.pmid: 16231970